Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for TOVX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 1998. Start Trial.
Date Value
June 30, 2026 11.34M
March 31, 2026 14.43M
December 31, 2025 13.06M
September 30, 2025 7.528M
June 30, 2025 12.12M
March 31, 2025 10.01M
December 31, 2024 11.61M
September 30, 2024 16.41M
June 30, 2024 16.59M
March 31, 2024 18.26M
December 31, 2023 23.18M
September 30, 2023 31.16M
June 30, 2023 34.25M
March 31, 2023 36.08M
December 31, 2022 41.79M
September 30, 2022 50.49M
June 30, 2022 52.27M
March 31, 2022 56.69M
December 31, 2021 67.32M
September 30, 2021 72.14M
June 30, 2021 74.29M
March 31, 2021 76.89M
December 31, 2020 6.227M
September 30, 2020 6.005M
June 30, 2020 8.059M
Date Value
March 31, 2020 10.08M
December 31, 2019 15.04M
September 30, 2019 18.65M
June 30, 2019 21.71M
March 31, 2019 24.69M
December 31, 2018 28.92M
September 30, 2018 9.549M
June 30, 2018 7.129M
March 31, 2018 11.04M
December 31, 2017 17.12M
September 30, 2017 21.05M
June 30, 2017 13.38M
March 31, 2017 13.47M
December 31, 2016 19.06M
September 30, 2016 4.549M
June 30, 2016 10.05M
March 31, 2016 15.10M
December 31, 2015 20.82M
September 30, 2015 31.81M
June 30, 2015 4.757M
March 31, 2015 12.05M
December 31, 2014 17.52M
September 30, 2014 3.286M
June 30, 2014 7.843M
March 31, 2014 11.16M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Ironwood Pharmaceuticals, Inc. 79.13M
Nkarta, Inc. 182.76M
Unicycive Therapeutics, Inc. 61.42M
OnKure Therapeutics, Inc. 176.39M
ACADIA Pharmaceuticals, Inc. 956.47M